Community post

New NIAID request for applications: Partnerships for the Development of Novel Therapeutics To Combat Select Antibiotic Resistant Bacteria and Fungi (R01, Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics and related countermeasures against antibiotic resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacteriaceae, or Candida auris. Applications must include a Product Development Strategy attachment. Substantive investment by industrial participants is highly encouraged.